첨단 원격의료 플랫폼 시장 분석 및 예측(-2035년) : 유형, 제품, 서비스, 기술, 구성 요소, 용도, 도입 형태, 최종 사용자, 기능, 솔루션

The global Advanced Telemedicine Platforms Market is projected to grow from $5.2 billion in 2025 to $12.4 billion by 2035, at a compound annual growth rate (CAGR) of 8.9%. This growth is driven by increasing healthcare digitization, rising demand for remote patient monitoring, and advancements in AI and IoT technologies enhancing telemedicine capabilities. The Advanced Telemedicine Platforms Market is characterized by a moderately consolidated structure, with the top segments being remote patient monitoring (40%) and virtual consultations (30%). Key product categories include software solutions, hardware devices, and integrated services. The market is driven by the increasing adoption of digital health solutions and the need for efficient healthcare delivery systems. In terms of volume, the market has seen a substantial increase in installations of telemedicine platforms, particularly in hospitals and clinics.

The competitive landscape features a mix of global and regional players, with global companies often leading in innovation and technology integration. The degree of innovation is high, driven by advancements in AI, machine learning, and data analytics. Mergers and acquisitions, as well as strategic partnerships, are prevalent as companies aim to expand their service offerings and geographic reach. Notable trends include collaborations between technology firms and healthcare providers to enhance platform capabilities and improve patient outcomes.

The Type segment in the advanced telemedicine platforms market is primarily categorized into real-time, store-and-forward, and remote patient monitoring. Real-time telemedicine, which includes live video conferencing, dominates due to its ability to provide immediate patient-physician interaction, crucial in emergency care and mental health services. Store-and-forward solutions are gaining traction in dermatology and radiology, where detailed image analysis is required. Remote patient monitoring is expanding rapidly, driven by chronic disease management and the increasing prevalence of wearable health technologies.

Technology in telemedicine platforms is segmented into software, hardware, and services. Software solutions lead the market, driven by the need for robust, secure platforms that facilitate seamless communication and data exchange. Cloud-based solutions are particularly in demand due to their scalability and cost-effectiveness. Hardware, including telemedicine carts and kiosks, supports the infrastructure, while services such as installation, maintenance, and training ensure optimal platform utilization. The integration of AI and machine learning is a notable trend, enhancing diagnostic accuracy and operational efficiency.

The Application segment encompasses teleconsultation, telecardiology, teleradiology, telepathology, and others. Teleconsultation is the most dominant subsegment, propelled by the need for accessible healthcare services, particularly in rural and underserved areas. Teleradiology is experiencing significant growth, supported by the increasing demand for radiological services and the shortage of radiologists. Telecardiology is also expanding, driven by the rising incidence of cardiovascular diseases and the need for continuous cardiac monitoring. Innovations in imaging and diagnostic technologies are further enhancing these applications.

End User segmentation includes healthcare providers, patients, and payers. Healthcare providers, including hospitals and clinics, are the primary users, leveraging telemedicine to extend their reach and improve patient outcomes. Patients are increasingly adopting these platforms for convenience and accessibility, particularly for follow-up consultations and chronic disease management. Payers, including insurance companies, are supporting telemedicine adoption by offering coverage for virtual visits, recognizing the cost-saving potential and improved care coordination. The COVID-19 pandemic has accelerated adoption across all end-user categories.

The Component segment is divided into software, hardware, and services. Software components, including electronic health records (EHR) integration and telehealth platforms, are crucial for enabling seamless communication and data management. Hardware components, such as cameras and diagnostic devices, support the delivery of remote care. Services, including consulting, implementation, and support, are essential for ensuring the successful deployment and operation of telemedicine solutions. The shift towards integrated solutions that combine multiple components is a key trend, enhancing the overall efficiency and effectiveness of telemedicine platforms.

Geographical Overview

North America: The advanced telemedicine platforms market in North America is highly mature, driven by robust healthcare infrastructure and widespread digital adoption. The United States and Canada are key players, with high demand from the healthcare and insurance sectors. The region's focus on reducing healthcare costs and improving patient access further accelerates market growth.

Europe: Europe exhibits moderate market maturity, with significant contributions from countries like Germany, the UK, and France. The demand is primarily driven by the aging population and government initiatives promoting digital health solutions. The region's regulatory environment supports telemedicine adoption, enhancing market potential.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in the telemedicine market, with countries like China, India, and Japan leading the charge. The market is driven by increasing healthcare needs, technological advancements, and government support. The region's large population and rising internet penetration are key factors propelling demand.

Latin America: Latin America's telemedicine market is in the nascent stage, with Brazil and Mexico being notable contributors. The region's demand is fueled by the need to improve healthcare access in remote areas and the increasing prevalence of chronic diseases. Economic constraints and infrastructure challenges remain barriers to rapid growth.

Middle East & Africa: The telemedicine market in the Middle East & Africa is emerging, with the UAE and South Africa as notable countries. The demand is driven by efforts to enhance healthcare accessibility and quality. However, the market faces challenges such as limited technological infrastructure and regulatory hurdles, impacting growth potential.

Key Trends and Drivers

Trend 1 Title: Integration of AI and Machine Learning

The integration of artificial intelligence (AI) and machine learning (ML) into telemedicine platforms is revolutionizing patient diagnosis and treatment. These technologies enable more accurate and faster analysis of medical data, leading to improved patient outcomes. AI-driven chatbots and virtual health assistants are increasingly being used to provide preliminary consultations and triage, reducing the burden on healthcare professionals. As AI and ML technologies continue to evolve, their application in telemedicine is expected to expand, offering more personalized and efficient healthcare services.

Trend 2 Title: Regulatory Support and Reimbursement Policies

Governments and healthcare regulators worldwide are increasingly recognizing the potential of telemedicine to improve healthcare access and reduce costs. This has led to the implementation of supportive regulatory frameworks and reimbursement policies that encourage the adoption of telemedicine platforms. For instance, during the COVID-19 pandemic, many countries expanded telehealth reimbursement policies, which are now being made permanent. These regulatory changes are driving the growth of the telemedicine market by making it financially viable for healthcare providers to offer remote services.

Trend 3 Title: Expansion of Remote Patient Monitoring

The demand for remote patient monitoring (RPM) solutions is rising as healthcare providers seek to manage chronic diseases more effectively and reduce hospital readmissions. Advanced telemedicine platforms are increasingly incorporating RPM capabilities, allowing continuous monitoring of patients' vital signs and health data from their homes. This trend is driven by the growing prevalence of chronic conditions such as diabetes and hypertension, as well as the need to provide care for aging populations. RPM technologies are enhancing patient engagement and enabling proactive healthcare management.

Trend 4 Title: Increased Adoption of Cloud-Based Solutions

Cloud-based telemedicine platforms are gaining traction due to their scalability, flexibility, and cost-effectiveness. These solutions allow healthcare providers to store and access patient data securely, facilitating seamless communication and collaboration among medical professionals. The adoption of cloud technology also supports the integration of various healthcare applications, enhancing the overall functionality of telemedicine platforms. As data security and privacy concerns are addressed, the shift towards cloud-based solutions is expected to accelerate, further driving market growth.

Trend 5 Title: Rise of Interoperability Standards

The development and adoption of interoperability standards are crucial for the seamless exchange of health information across different telemedicine platforms and electronic health record (EHR) systems. Interoperability ensures that patient data can be shared and accessed efficiently, improving care coordination and reducing the risk of medical errors. Industry initiatives and collaborations are underway to establish common standards, which are essential for the widespread adoption of telemedicine. As these standards become more prevalent, they will facilitate the integration of telemedicine into mainstream healthcare systems, enhancing its utility and effectiveness.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by Deployment
• 2.8 Key Market Highlights by End User
• 2.9 Key Market Highlights by Functionality
• 2.10 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Real-time Telemedicine
  • 4.1.2 Remote Patient Monitoring
  • 4.1.3 Store-and-Forward
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Telemedicine Software
  • 4.2.2 Telemedicine Devices
  • 4.2.3 Telemedicine Kits
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Consultation Services
  • 4.3.2 Diagnostic Services
  • 4.3.3 Treatment Services
  • 4.3.4 Monitoring Services
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Cloud-based
  • 4.4.2 AI and Machine Learning
  • 4.4.3 Blockchain
  • 4.4.4 IoT
  • 4.4.5 5G
  • 4.4.6 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Software
  • 4.5.2 Hardware
  • 4.5.3 Services
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Cardiology
  • 4.6.2 Dermatology
  • 4.6.3 Neurology
  • 4.6.4 Orthopedics
  • 4.6.5 Psychiatry
  • 4.6.6 Others
• 4.7 Market Size & Forecast by Deployment (2020-2035)
  • 4.7.1 On-premise
  • 4.7.2 Cloud-based
  • 4.7.3 Hybrid
  • 4.7.4 Others
• 4.8 Market Size & Forecast by End User (2020-2035)
  • 4.8.1 Hospitals
  • 4.8.2 Clinics
  • 4.8.3 Home Care
  • 4.8.4 Ambulatory Surgical Centers
  • 4.8.5 Others
• 4.9 Market Size & Forecast by Functionality (2020-2035)
  • 4.9.1 Video Conferencing
  • 4.9.2 Remote Monitoring
  • 4.9.3 Data Management
  • 4.9.4 Others
• 4.10 Market Size & Forecast by Solutions (2020-2035)
  • 4.10.1 Patient Management
  • 4.10.2 Clinical Workflow
  • 4.10.3 Teleconsultation
  • 4.10.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 Deployment
    • 5.2.1.8 End User
    • 5.2.1.9 Functionality
    • 5.2.1.10 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 Deployment
    • 5.2.2.8 End User
    • 5.2.2.9 Functionality
    • 5.2.2.10 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 Deployment
    • 5.2.3.8 End User
    • 5.2.3.9 Functionality
    • 5.2.3.10 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 Deployment
    • 5.3.1.8 End User
    • 5.3.1.9 Functionality
    • 5.3.1.10 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 Deployment
    • 5.3.2.8 End User
    • 5.3.2.9 Functionality
    • 5.3.2.10 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 Deployment
    • 5.3.3.8 End User
    • 5.3.3.9 Functionality
    • 5.3.3.10 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 Deployment
    • 5.4.1.8 End User
    • 5.4.1.9 Functionality
    • 5.4.1.10 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 Deployment
    • 5.4.2.8 End User
    • 5.4.2.9 Functionality
    • 5.4.2.10 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 Deployment
    • 5.4.3.8 End User
    • 5.4.3.9 Functionality
    • 5.4.3.10 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 Deployment
    • 5.4.4.8 End User
    • 5.4.4.9 Functionality
    • 5.4.4.10 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 Deployment
    • 5.4.5.8 End User
    • 5.4.5.9 Functionality
    • 5.4.5.10 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 Deployment
    • 5.4.6.8 End User
    • 5.4.6.9 Functionality
    • 5.4.6.10 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 Deployment
    • 5.4.7.8 End User
    • 5.4.7.9 Functionality
    • 5.4.7.10 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 Deployment
    • 5.5.1.8 End User
    • 5.5.1.9 Functionality
    • 5.5.1.10 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 Deployment
    • 5.5.2.8 End User
    • 5.5.2.9 Functionality
    • 5.5.2.10 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 Deployment
    • 5.5.3.8 End User
    • 5.5.3.9 Functionality
    • 5.5.3.10 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 Deployment
    • 5.5.4.8 End User
    • 5.5.4.9 Functionality
    • 5.5.4.10 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 Deployment
    • 5.5.5.8 End User
    • 5.5.5.9 Functionality
    • 5.5.5.10 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 Deployment
    • 5.5.6.8 End User
    • 5.5.6.9 Functionality
    • 5.5.6.10 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 Deployment
    • 5.6.1.8 End User
    • 5.6.1.9 Functionality
    • 5.6.1.10 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 Deployment
    • 5.6.2.8 End User
    • 5.6.2.9 Functionality
    • 5.6.2.10 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 Deployment
    • 5.6.3.8 End User
    • 5.6.3.9 Functionality
    • 5.6.3.10 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 Deployment
    • 5.6.4.8 End User
    • 5.6.4.9 Functionality
    • 5.6.4.10 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 Deployment
    • 5.6.5.8 End User
    • 5.6.5.9 Functionality
    • 5.6.5.10 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Teladoc Health
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Amwell
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Doctor on Demand
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 MDLive
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 GlobalMed
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 American Well
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Philips Healthcare
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 GE Healthcare
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Siemens Healthineers
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Medtronic
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Cerner Corporation
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Epic Systems
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Allscripts Healthcare Solutions
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Athenahealth
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Cisco Systems
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Zoom Video Communications
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 VSee
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 InTouch Health
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Vidyo
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 CareClix
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us